These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 18544440)
21. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer. Salama JK; Stenson KM; List MA; Mell LK; Maccracken E; Cohen EE; Blair E; Vokes EE; Haraf DJ Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1060-5. PubMed ID: 18936351 [TBL] [Abstract][Full Text] [Related]
22. Long-term survival following salvage reirradiation with concurrent chemotherapy for recurrent head and neck cancer. Watkins JM; Stuart RK; Davis BK; Day TA; Chaudharry UB; Sharma AK J S C Med Assoc; 2008 Feb; 104(2):36-9. PubMed ID: 18396601 [No Abstract] [Full Text] [Related]
23. [Single suture closure and surgical staplers in neck interventions after previous radiotherapy]. Dost P; Budach WD; Reide WD Laryngorhinootologie; 1997 Jun; 76(6):364-7. PubMed ID: 9333281 [TBL] [Abstract][Full Text] [Related]
24. Expanding role of the medical oncologist in the management of head and neck cancer. Choong N; Vokes E CA Cancer J Clin; 2008; 58(1):32-53. PubMed ID: 18096865 [TBL] [Abstract][Full Text] [Related]
25. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer. Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456 [TBL] [Abstract][Full Text] [Related]
26. The chemoradiation paradigm in head and neck cancer. Seiwert TY; Salama JK; Vokes EE Nat Clin Pract Oncol; 2007 Mar; 4(3):156-71. PubMed ID: 17327856 [TBL] [Abstract][Full Text] [Related]
27. The effectiveness of salvage surgery after the failure of primary concomitant chemoradiation in head and neck cancer. Richey LM; Shores CG; George J; Lee S; Couch MJ; Sutton DK; Weissler MC Otolaryngol Head Neck Surg; 2007 Jan; 136(1):98-103. PubMed ID: 17210342 [TBL] [Abstract][Full Text] [Related]
28. Future chemotherapy and radiotherapy options in head and neck cancer. Merlano M; Mattiot VP Expert Rev Anticancer Ther; 2006 Mar; 6(3):395-403. PubMed ID: 16503856 [TBL] [Abstract][Full Text] [Related]
29. Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer. Choe KS; Salama JK; Stenson KM; Blair EA; Witt ME; Cohen EE; Haraf DJ; Vokes EE Radiother Oncol; 2010 Nov; 97(2):318-21. PubMed ID: 20934766 [TBL] [Abstract][Full Text] [Related]
30. Alternating chemotherapy and radiotherapy in locally advanced head and neck cancer: an alternative? Merlano M Oncologist; 2006 Feb; 11(2):146-51. PubMed ID: 16476835 [TBL] [Abstract][Full Text] [Related]
31. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Caudell JJ; Schaner PE; Meredith RF; Locher JL; Nabell LM; Carroll WR; Magnuson JS; Spencer SA; Bonner JA Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):410-5. PubMed ID: 18635320 [TBL] [Abstract][Full Text] [Related]
32. Adjuvant therapy in patients with resected poor-risk head and neck cancer. Bernier J; Vermorken JB; Koch WM J Clin Oncol; 2006 Jun; 24(17):2629-35. PubMed ID: 16763276 [TBL] [Abstract][Full Text] [Related]
33. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. Janot F; de Raucourt D; Benhamou E; Ferron C; Dolivet G; Bensadoun RJ; Hamoir M; Géry B; Julieron M; Castaing M; Bardet E; Grégoire V; Bourhis J J Clin Oncol; 2008 Dec; 26(34):5518-23. PubMed ID: 18936479 [TBL] [Abstract][Full Text] [Related]
34. Current and emerging standards of concomitant chemoradiotherapy. Adelstein DJ; Rodriguez CP Semin Oncol; 2008 Jun; 35(3):211-20. PubMed ID: 18544436 [TBL] [Abstract][Full Text] [Related]
35. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862 [TBL] [Abstract][Full Text] [Related]
36. [Reirradiation for recurrent or second primary head and neck cancers]. Mouttet-Audouard R; Gras L; Comet B; Lartigau E Bull Cancer; 2011 Dec; 98(12):1477-88. PubMed ID: 22157636 [TBL] [Abstract][Full Text] [Related]
37. Outcomes following reirradiation of patients with head and neck cancer. Goldstein DP; Karnell LH; Yao M; Chamberlin GP; Nguyen TX; Funk GF Head Neck; 2008 Jun; 30(6):765-70. PubMed ID: 18286493 [TBL] [Abstract][Full Text] [Related]
38. Evidence based and new developments in re-irradiation for recurrent or second primary head and neck cancers. Mouttet-Audouard R; Gras L; Comet B; Lartigau E Curr Opin Otolaryngol Head Neck Surg; 2012 Apr; 20(2):137-41. PubMed ID: 22249172 [TBL] [Abstract][Full Text] [Related]
39. Reirradiation for recurrent head and neck cancer. Patel PR; Salama JK Expert Rev Anticancer Ther; 2012 Sep; 12(9):1177-89. PubMed ID: 23098118 [TBL] [Abstract][Full Text] [Related]
40. Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy. Milano MT; Vokes EE; Salama JK; Stenson KM; Kao J; Witt ME; Mittal BB; Argiris A; Weichselbaum RR; Haraf DJ Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1096-106. PubMed ID: 15752889 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]